Reciprocal absence of cross-resistance between eltrombopag and romiplostim in two patients with refractory immune thrombocytopenic purpura

被引：0
|
作者：
Scaramucci, Laura [1 ]
Giovannini, Marco [1 ]
Niscola, Pasquale [1 ]
Tendas, Andrea [1 ]
Perrotti, Alessio [1 ]
de Fabritiis, Paolo [1 ]
机构：
[1] St Eugenio Hosp, Div Haematol, I-00144 Rome, Italy
来源：
BLOOD TRANSFUSION | 2014年 / 12卷 / 04期
关键词：
TPO mimetics; ITP; eltrombopag; romiplostim; THROMBOPOIETIN RECEPTOR AGONISTS;
D O I：
10.2450/2014.0246-13
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：605 / 607
页数：3
相关论文
共 21 条
  • [1] No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura
    D'Arena, Giovanni
    Guariglia, Roberto
    Mansueto, Giovanna
    Martorelli, Maria Carmen
    Pietrantuono, Giuseppe
    Villani, Oreste
    Lerose, Rosa
    Musto, Pellegrino
    BLOOD, 2013, 121 (07) : 1240 - 1242
  • [2] Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag
    Chouhan, Jyoti D.
    Herrington, Jon D.
    PHARMACOTHERAPY, 2010, 30 (07): : 666 - 683
  • [3] Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of a Romiplostim Biosimilar in Chronic Refractory Immune Thrombocytopenic Purpura (ITP) Patients
    Inderjeet Singh
    R. K. Swetha
    Ronak Patel
    Meghana Dahiya
    Vinu Jose
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 111 - 121
  • [4] Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of a Romiplostim Biosimilar in Chronic Refractory Immune Thrombocytopenic Purpura (ITP) Patients
    Singh, Inderjeet
    Swetha, R. K.
    Patel, Ronak
    Dahiya, Meghana
    Jose, Vinu
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (01) : 111 - 121
  • [5] Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature review
    Chua, Su J.
    Morton, Mark R.
    Svigos, John
    Ross, David M.
    Kane, Simon
    OBSTETRIC MEDICINE, 2020, 13 (01) : 45 - 50
  • [6] Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura
    Oo, Zayar
    Manvar, Kapilkumar
    Wang, Jen Chin
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2022, 10
  • [7] Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy
    Mitsuhashi, Kenjiro
    Ishiyama, Midori
    Imai, Yoichi
    Shiseki, Masayuki
    Mori, Naoki
    Teramura, Masanao
    Seshimo, Akiyoshi
    Motoji, Toshiko
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (06) : 798 - 800
  • [8] Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura
    Arnold, Donald M.
    Nazi, Ishac
    Santos, Aurelio
    Chan, Howard
    Heddle, Nancy M.
    Warkentin, Theodore E.
    Kelton, John G.
    BLOOD, 2010, 115 (01) : 29 - 31
  • [9] Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports
    Gilreath, Jeffrey A.
    Wei, Mei
    Paul, Shilpa
    Parker, Charles J.
    Stenehjem, David D.
    Rodgers, George M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) : 719 - 723
  • [10] An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
    Shirasugi, Yukari
    Ando, Kiyoshi
    Miyazaki, Koji
    Tomiyama, Yoshiaki
    Iwato, Koji
    Okamoto, Shinichiro
    Kurokawa, Mineo
    Kirito, Keita
    Hashino, Satoshi
    Ninomiya, Haruhiko
    Mori, Shinichiro
    Yonemura, Yuji
    Usuki, Kensuke
    Wei, Helen
    Lizambri, Richard
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (06) : 652 - 659
123